Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:56 pm Sale | 2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Armistice Capital, LLC | 188,438 4.990% | -131,318 (-41.07%) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Adage Capital Management L.P. | 325,000 9.380% | 106,187 (+48.53%) | Filing History |
| 2024-11-14 6:57 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Vivo Capital Fund VIII L.P. | 141,879 4.000% | 141,879 (New Position) | Filing History |
| 2024-11-14 6:19 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital, LLC | 356,117 9.990% | 356,117 (New Position) | Filing History |
| 2024-11-14 5:03 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Armistice Capital, LLC | 319,756 9.990% | 319,756 (New Position) | Filing History |
| 2024-11-14 4:37 pm Sale | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Alyeska Investment Group, L.P. | 146,472 4.800% | -140,599 (-48.98%) | Filing History |
| 2024-11-14 4:34 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR Advisors, Ltd. | 125,069 4.000% | 125,069 (New Position) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Adage Capital Management L.P. | 218,813 7.120% | 218,813 (New Position) | Filing History |
| 2024-09-12 4:21 pm Purchase | 2024-09-09 | 13G | Aligos Therapeutics, Inc. ALGS | ICS OPPORTUNITIES II LLC | 125,451 4.100% | 125,451 (New Position) | Filing History |
| 2024-02-14 5:07 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital, LLC | 290,566 9.990% | 132,631 (+83.98%) | Filing History |
| 2024-02-14 4:37 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR Advisors, Ltd. | 238,857 8.200% | 146,466 (+158.53%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Baker Bros. Advisors LP | 146,561 4.990% | 63,505 (+76.46%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | TANG CAPITAL MANAGEMENT, LLC | 87,594 3.000% | -25,062 (-22.25%) | Filing History |
| 2024-02-14 3:23 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Armistice Capital, LLC | 288,593 9.990% | 288,593 (New Position) | Filing History |
| 2024-02-14 1:53 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Alyeska Investment Group, L.P. | 287,071 9.990% | 287,071 (New Position) | Filing History |
| 2024-02-08 5:44 pm Unchanged | 2023-11-02 | 13D | Aligos Therapeutics, Inc. ALGS | Versant Venture Capital VI, L.P. | 58,317 1.900% | 0 (Unchanged) | Filing History |
| 2023-11-07 5:16 pm Purchase | 2023-10-25 | 13G | Aligos Therapeutics, Inc. ALGS | Roche Finance Ltd | 441,038 15.350% | 317,344 (+256.56%) | Filing History |
| 2023-11-06 4:05 pm Purchase | 2023-10-25 | 13D | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 155,530 5.300% | 48,411 (+45.19%) | Filing History |
| 2023-11-02 4:08 pm Purchase | 2023-10-23 | 13G | Aligos Therapeutics, Inc. ALGS | Deep Track Capital, LP | 291,839 9.990% | 291,839 (New Position) | Filing History |
| 2023-02-14 4:10 pm Sale | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR Advisors, Ltd. | 92,391 5.800% | -2,212 (-2.34%) | Filing History |